6236.TWO Neith Corporation

Healthcare Biotechnology Taiwan OTC Exchange
15.00 TWD
Close of Nov 5, 2026
13.85 29.30
Market cap
TWD 625M
P/E
1,500.0x
P/B
4.45x
ROE
-0.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6236.TWO undervalued?

Graham number

The Graham number of Neith Corporation cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Neith Corporation fundamental analysis

No fundamental analysis for Neith Corporation yet.

Neith Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Neith Corporation

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company provides nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also offers genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy…

Full company profile